Serra Virginia, De Luca Francesco, Savino Ketty, Pinto Maurizio Del, Castellani Claudia, Fiaschini Paola, Tomasello Laura, Cavallini Claudio
Cardiology and Cardiovascular Physiopathology, University of Perugia, Perugia, Italy.
Department of Cardiology, Perugia Hospital, Perugia, Italy.
J Cardiovasc Echogr. 2021 Jan-Mar;31(1):42-44. doi: 10.4103/jcecho.jcecho_109_20. Epub 2021 May 21.
Primary cardiac lymphoma (PCL) is among the rarest heart neoplasms. Its estimated incidence is about 1%-2% among primary cardiac tumor and 0.5% of extranodal lymphoma. It usually causes heart failure, pericardial effusion, tamponade, and arrhythmias. Prognosis is poor; treatment is combined medical and surgical. We described the case of a 62-year-old male with PLC that presented with syncope and cardiac tamponade, submitted to R-CHOP therapy because of failure of surgery. Clinical state is stable 3 months after diagnosis and first chemotherapy cycle.
原发性心脏淋巴瘤(PCL)是最罕见的心脏肿瘤之一。其在原发性心脏肿瘤中的估计发病率约为1%-2%,在结外淋巴瘤中占0.5%。它通常会导致心力衰竭、心包积液、心脏压塞和心律失常。预后较差;治疗采用药物和手术相结合的方式。我们描述了一例62岁患有原发性心脏淋巴瘤的男性患者,该患者表现为晕厥和心脏压塞,因手术失败而接受R-CHOP治疗。诊断和首个化疗周期3个月后临床状态稳定。